Analysis of early neonatal case fatality rate among newborns with congenital hydrocephalus, a 2000-2014 multi-country registry-based study.
ETOPFA
birth defects
case fatality rate
congenital hydrocephalus
early neonatal deaths
population surveillance
prevalence
trends
Journal
Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004
Informations de publication
Date de publication:
15 07 2022
15 07 2022
Historique:
revised:
05
04
2022
received:
09
02
2022
accepted:
29
04
2022
pubmed:
29
5
2022
medline:
19
7
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Congenital hydrocephalus (CH) comprises a heterogeneous group of birth anomalies with a wide-ranging prevalence across geographic regions and registry type. The aim of the present study was to analyze the early neonatal case fatality rate (CFR) and total birth prevalence of newborns diagnosed with CH. Data were provided by 25 registries from four continents participating in the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) on births ascertained between 2000 and 2014. Two CH rates were calculated using a Poisson distribution: early neonatal CFR (death within 7 days) per 100 liveborn CH cases (CFR) and total birth prevalence rate (BPR) per 10,000 births (including live births and stillbirths) (BPR). Heterogeneity between registries was calculated using a meta-analysis approach with random effects. Temporal trends in CFR and BPR within registries were evaluated through Poisson regression modeling. A total of 13,112 CH cases among 19,293,280 total births were analyzed. The early neonatal CFR was 5.9 per 100 liveborn cases, 95% confidence interval (CI): 5.4-6.8. The CFR among syndromic cases was 2.7 times (95% CI: 2.2-3.3) higher than among non-syndromic cases (10.4% [95% CI: 9.3-11.7] and 4.4% [95% CI: 3.7-5.2], respectively). The total BPR was 6.8 per 10,000 births (95% CI: 6.7-6.9). Stratified by elective termination of pregnancy for fetal anomalies (ETOPFA), region and system, higher CFR were observed alongside higher BPR rates. The early neonatal CFR and total BPR did not show temporal variation, with the exception of a CFR decrease in one registry. Findings of early neonatal CFR and total BPR were highly heterogeneous among registries participating in ICBDSR. Most registries with higher CFR also had higher BPR. Differences were attributable to type of registry (hospital-based vs. population-based), ETOPFA (allowed yes or no) and geographical regions. These findings contribute to the understanding of regional differences of CH occurrence and early neonatal deaths.
Sections du résumé
BACKGROUND
Congenital hydrocephalus (CH) comprises a heterogeneous group of birth anomalies with a wide-ranging prevalence across geographic regions and registry type. The aim of the present study was to analyze the early neonatal case fatality rate (CFR) and total birth prevalence of newborns diagnosed with CH.
METHODS
Data were provided by 25 registries from four continents participating in the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) on births ascertained between 2000 and 2014. Two CH rates were calculated using a Poisson distribution: early neonatal CFR (death within 7 days) per 100 liveborn CH cases (CFR) and total birth prevalence rate (BPR) per 10,000 births (including live births and stillbirths) (BPR). Heterogeneity between registries was calculated using a meta-analysis approach with random effects. Temporal trends in CFR and BPR within registries were evaluated through Poisson regression modeling.
RESULTS
A total of 13,112 CH cases among 19,293,280 total births were analyzed. The early neonatal CFR was 5.9 per 100 liveborn cases, 95% confidence interval (CI): 5.4-6.8. The CFR among syndromic cases was 2.7 times (95% CI: 2.2-3.3) higher than among non-syndromic cases (10.4% [95% CI: 9.3-11.7] and 4.4% [95% CI: 3.7-5.2], respectively). The total BPR was 6.8 per 10,000 births (95% CI: 6.7-6.9). Stratified by elective termination of pregnancy for fetal anomalies (ETOPFA), region and system, higher CFR were observed alongside higher BPR rates. The early neonatal CFR and total BPR did not show temporal variation, with the exception of a CFR decrease in one registry.
CONCLUSIONS
Findings of early neonatal CFR and total BPR were highly heterogeneous among registries participating in ICBDSR. Most registries with higher CFR also had higher BPR. Differences were attributable to type of registry (hospital-based vs. population-based), ETOPFA (allowed yes or no) and geographical regions. These findings contribute to the understanding of regional differences of CH occurrence and early neonatal deaths.
Identifiants
pubmed: 35633200
doi: 10.1002/bdr2.2045
pmc: PMC9288486
mid: NIHMS1812338
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
631-644Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Paediatr Perinat Epidemiol. 2019 Nov;33(6):436-448
pubmed: 31637749
Rev Panam Salud Publica. 2019 Feb 14;43:e2
pubmed: 31093226
Paediatr Perinat Epidemiol. 2001 Jul;15(3):315-6
pubmed: 11489162
Neurotoxicology. 2017 Jul;61:33-45
pubmed: 27000516
Pediatr Neurol. 2011 Aug;45(2):67-71
pubmed: 21763944
Ann Hum Genet. 1971 Feb;34(3):295-305
pubmed: 4926846
Ann Neurol. 2017 Jun;81(6):890-897
pubmed: 28556411
Birth Defects Res. 2020 Dec;112(20):1787-1801
pubmed: 33067932
J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1253-9
pubmed: 24667207
Ultrasound Obstet Gynecol. 2017 Apr;49(4):450-459
pubmed: 27091707
Glob J Health Sci. 2014 Apr 27;6(5):1-8
pubmed: 25168985
Am J Med Genet. 2001 Jul 22;102(1):36-43
pubmed: 11471170
JAMA. 2002 Mar 27;287(12):1561-7
pubmed: 11911759
Ann Epidemiol. 2021 Apr;56:61-69.e3
pubmed: 33253899
Eur J Paediatr Neurol. 2010 Mar;14(2):150-5
pubmed: 19410489
PLoS One. 2018 Oct 1;13(10):e0204926
pubmed: 30273390
J Neurosurg. 2018 Apr 1;:1-15
pubmed: 29701543
J Matern Fetal Neonatal Med. 2019 Nov;32(21):3666-3674
pubmed: 29739244
J Med Ethics. 2006 Nov;32(11):652-7
pubmed: 17074823
Ann Hum Biol. 2004 Mar-Apr;31(2):263-9
pubmed: 15204368
Metab Brain Dis. 2018 Jun;33(3):837-842
pubmed: 29388147
Paediatr Perinat Epidemiol. 2020 Mar;34(2):122-129
pubmed: 32101337
J Neurosurg. 2005 Aug;103(2 Suppl):111; discussion 111-2
pubmed: 16370274
Oncotarget. 2018 Jan 13;9(18):14472-14480
pubmed: 29581857
Neurosurg Focus. 2016 Nov;41(5):E3
pubmed: 27798989
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120